Coty Stock COTY
Coty stock (COTY): Quarterly and annual results since 2023 from Quarterly Report and SEC filings: revenue, earnings, balance sheet, cash flow and management guidance, every figure with its source. As of 08/2026, quarterly reporting. Stock analysis by NadirAlpha. Coty stock (COTY): listed on NYSE. NadirAlpha has evaluated 56 original documents, cross-checked every figure automatically and linked each to its source; sources as of 08/2026. Revenue Q4 FY2026 (Apr to Jun 2026): USD 1.3 billion (+1% year on year). Latest reported (Q4 FY2026 (Apr to Jun 2026)): Financial leverage ratio, Total debt, Financial net debt. Latest reading: Margin compressing, Guidance initiated, Divestiture.
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
Coty Current Status
Summary of the most recent reporting period of Coty (Q4 FY2026): core figures, drivers and management statements, every figure with a source number. NadirAlpha methodology
Assessment by NadirAlpha, as of Q4 FY2026 (Apr to Jun 2026).
“We closed FY26 on a stronger note, delivering sales and profit ahead of our targets, growing free cash flow even in the face of business headwinds, all while establishing a clear strategic framework and taking decisive action to steadily strengthen our core business in FY27 and beyond.”
“In sum, our Q4 results provide early signs of stabilization, although the recovery will not be linear. FY27 will be a transition year as we strengthen our core business and continue shaping a simpler, more focused Coty, factoring in both the Gucci exit by FY28 and final portfolio decisions related to our strategic review of Consumer Beauty by the end of CY26.”
Coty Stock: Key Figures ($ million)
NadirAlpha shows fiscal years, half-years and quarters of Coty one below the other, most recently Q4 FY2026; every figure is clickable and leads to raw value, location and source. NadirAlpha extracts all values automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original. NadirAlpha methodology
All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.
Fiscal years
| Period | Calendar quarter | Revenue | Op. income | Op. income (adj.) | Net income | EPS ($) | EPS adj. ($) | EBITDA (adj.) | OCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 | Q3/2025–Q2/2026 | 5,806.6 | -81.5 | 626.7 | -604.8 | -0.70 | 0.21 | 846.9 | 537.8 | 33 |
| FY2025 | Q3/2024–Q2/2025 | 5,892.9 | 241.1 | 773.2 | -367.9 | -0.44 | 0.22 | 197.1 | 492.6 | 124 |
| FY2024 | Q3/2023–Q2/2024 | 6,118 | 546.7 | 863.4 | 89.4 | 0.09 | 0.37 | 1,091.1 | 614.6 | 116 |
Quarters
| Period | Calendar quarter | Published | Revenue | Op. income | Op. income (adj.) | Net income | EPS ($) | EPS adj. ($) | EBITDA (adj.) | FCF | Cash | Net Debt | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-Q4* | Q2/2026 | 2026-08-19 | 1,269.2 | -42.7 | 39.5 | -141 | -0.16*≈ | -0.02 | 93.6 | 72.6 | 176.1 | 2,871.7 | 132 |
| 2026-Q3* | Q1/2026 | 2026-05-05 | 1,281.6 | -372 | 72.4 | -408.1 | -0.47 | -0.03 | 127 | -248.7 | 257.1 | 2,914.4 | 131 |
| 2026-Q2* | Q4/2025 | 2026-02-05 | 1,678.6 | 148.2 | 274.3 | -123.6 | -0.14 | 0.14 | 330.2 | 513.1 | 436.7 | 2,552.5 | 129 |
| 2026-Q1* | Q3/2025 | 2025-11-05 | 1,577.2 | 185 | 240.5 | 67.9 | 0.07 | 0.12 | 296.1 | 11.2 | 264.6 | 3,760 | 127 |
| 2025-Q4* | Q2/2025 | 2025-08-20 | 1,252.4 | 15.5 | 67.7 | -68.8 | -0.08*≈ | – | 126.7 | 34.9 | 257.1 | 3,701.9 | 24 |
| 2025-Q3* | Q1/2025 | 2025-05-06 | 1,299.1 | -280.4 | 147.9 | -405.7 | -0.47 | 0.01 | 204.2 | -168.4 | 243.5 | 3,562 | 22 |
| 2025-Q2* | Q4/2024 | 2025-02-10 | 1,669.9 | 268.2 | 333.7 | 23.7 | 0.02 | 0.11 | 390.7 | 419 | 249.6 | 3,151.8 | 20 |
| 2025-Q1* | Q3/2024 | 2024-10-15 | 1,671.5 | 237.8 | 303.6 | 82.9 | 0.09 | 0.15 | 360.1 | -7.9 | 283.6 | 3,654.1 | 17 |
| 2024-Q4* | Q2/2024 | 2024-08-20 | 1,363.4 | 34.7 | 108 | -96.9 | -0.10*≈ | -0.02≈ | 164.5 | 116.7 | 300.8 | 3,544 | 116 |
| 2024-Q3* | Q1/2024 | 2024-05-06 | 1,385.6 | 77.8 | 143.9 | 3.8 | 0.00 | 0.05 | 199.9 | -234.3 | 260.2 | 3,646.5 | 13 |
| 2024-Q2* | Q4/2023 | 2024-02-07 | 1,727.6 | 236.7 | 309.3 | 180.9 | 0.20 | 0.25 | 366.4 | 363 | 450 | 3,241.8 | 11 |
| 2024-Q1* | Q3/2023 | 2023-11-07 | 1,641.4 | 197.5 | 302.2 | 1.6 | 0.00 | 0.09 | 360.3 | 124 | 280 | 3,856.2 | 109 |
Coty Balance Sheet & Cash Flow ($ million)
Balance sheet and cash flow of Coty up to Q4 FY2026 in $ million: net debt = financial debt minus cash, free cash flow = operating cash flow minus capex, every input sourced. NadirAlpha extracts all values automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original. NadirAlpha methodology
Fiscal years
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 | Q3/2025–Q2/2026 | 2026-08-19 | 176.1 | 3,047.8 | 2,871.7 | 482.2 | 537.8 | 189.6 | 348.2 | 132 |
| FY2025 | Q3/2024–Q2/2025 | 2025-08-20 | 257.1 | 3,959 | 3,701.9 | 420 | 492.6 | 215 | 277.6 | 124 |
| FY2024 | Q3/2023–Q2/2024 | 2024-08-20 | 300.8 | 3,844.8 | 3,544 | 421.1 | 614.6 | 245.2 | 369.4 | 116 |
Quarters
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-Q4 | Q2/2026 | 2026-08-19 | 176.1 | 3,047.8 | 2,871.7 | 128.1 | 116 | 43.4 | 72.6 | 132 |
| 2026-Q3 | Q1/2026 | 2026-05-05 | 257.1 | 3,171.5 | 2,914.4 | 129.1 | -203.1 | 45.6 | -248.7 | 131 |
| 2026-Q2 | Q4/2025 | 2026-02-05 | 436.7 | 2,989.2 | 2,552.5 | 130.1 | 559.7 | 46.6 | 513.1 | 129 |
| 2026-Q1 | Q3/2025 | 2025-11-05 | 264.6 | 4,024.6 | 3,760 | 94.9 | 65.2 | 54 | 11.2 | 127 |
| 2025-Q4 | Q2/2025 | 2025-08-20 | 257.1 | 3,959 | 3,701.9 | 104.7 | 83.2 | 48.3 | 34.9 | 24 |
| 2025-Q3 | Q1/2025 | 2025-05-06 | 243.5 | 3,805.5 | 3,562 | 105.1 | -122.5 | 45.9 | -168.4 | 22 |
| 2025-Q2 | Q4/2024 | 2025-02-10 | 249.6 | 3,401.4 | 3,151.8 | 105.6 | 464.5 | 45.5 | 419 | 20 |
| 2025-Q1 | Q3/2024 | 2024-11-06 | 283.6 | 3,937.7 | 3,654.1 | 104.6 | 67.4 | 75.3 | -7.9 | 119 |
| 2024-Q4 | Q2/2024 | 2024-08-20 | 300.8 | 3,844.8 | 3,544 | 104.5 | 176.5 | 59.8 | 116.7 | 116 |
| 2024-Q3 | Q1/2024 | 2024-05-06 | 260.2 | 3,906.7 | 3,646.5 | 104.4 | -170 | 64.3 | -234.3 | 13 |
| 2024-Q2 | Q4/2023 | 2024-02-07 | 450 | 3,691.8 | 3,241.8 | 105.4 | 421.9 | 58.9 | 363 | 11 |
| 2024-Q1 | Q3/2023 | 2023-11-07 | 280 | 4,136.2 | 3,856.2 | 106.8 | 186.2 | 62.2 | 124 | 109 |
Coty Guidance Tracking (latest per metric/period · 27/37)
All forecasts (guidance) of the Coty management and their later outcome: per metric and period the most recent statement applies, the status is checked against the reported actuals. NadirAlpha methodology
Actuals: revenue in $m · EPS in $ per share
Direction: confirmedcutinitiatedraised Verdict: beatin linemisspending
| For period | Guided on | Metric | Guided | Actual | Verdict | Direction | Source |
|---|---|---|---|---|---|---|---|
| 2027-Q1 | 2026-08-19 | Gross margin (non-GAAP) | decline by approximately 50 to 100 basis points year-over-year | – | 32 | ||
| 2027-Q1 | 2026-08-19 | EPS (non-GAAP) | 0.11–0.13 | – | 32 | ||
| 2027-Q1 | 2026-08-19 | EBITDA (adjusted) | decline by a low-teens percentage | – | 32 | ||
| FY2026 | 2026-05-05 | EPS (non-GAAP) | 0.33–0.35 | 0.21 | 31 | ||
| FY2026 | 2026-05-05 | EBITDA (adjusted) | 838–848 | 846.9 | 31 | ||
| FY2026 | 2026-05-05 | Cost reduction efforts | ~80 | – | – | 30 | |
| FY2026 | 2025-11-05 | Cost reduction | ~80 | – | – | 28 | |
| 2026-Q3 | 2026-02-05 | Revenue | decline | 1,281.6 | – | – | 28 |
| 2026-Q3 | 2026-02-05 | Gross margin (GAAP) | pressured | – | – | 28 | |
| 2026-Q3 | 2026-02-05 | EBITDA (adjusted) | 100–110 | 127 | 29 | ||
| 2026-Q2 | 2025-11-05 | Revenue | roughly flat versus the prior year | 1,678.6 | – | 26 | |
| 2026-Q2 | 2025-11-05 | EPS (non-GAAP) | 0.18–0.21 | 0.14 | 27 | ||
| 2026-Q2 | 2025-11-05 | EBITDA (adjusted) | low-to-mid teens percentage decline | 330.2 | – | 27 | |
| 2026-Q2 | 2025-11-05 | LFL net revenue | -5–-3% | – | – | 27 | |
| 2026-H2 | 2025-11-05 | Revenue | return to growth versus the prior year | – | 26 | ||
| 2026-H2 | 2025-11-05 | Gross margin (GAAP) | pressured in second quarter; some easing in second half | – | 26 | ||
| FY2025 | 2025-05-07 | Revenue | will decline in the mid-single digit percentage | 5,892.9 | – | 23 | |
| FY2025 | 2025-05-07 | Gross margin (GAAP) | will remain in the mid-sixties | – | – | 23 | |
| FY2025 | 2025-05-07 | Cost reduction savings | ~120 | – | – | 23 | |
| FY2025 | 2025-05-06 | EPS (GAAP) | 0.49–0.5 | -0.44 | 22 | ||
| FY2025 | 2025-05-06 | EBITDA margin | ~18.5% | – | – | 22 | |
| FY2025 | 2025-05-06 | EBITDA (adjusted) | roughly flattish | 197.1 | – | 22 | |
| FY2025 | 2025-05-06 | Free cash flow | ~300 | – | – | 22 | |
| FY2025 | 2025-02-10 | EPS (non-GAAP) | 0.5–0.52 | 0.22 | 21 | ||
| FY2025 | 2024-08-20 | LFL revenue growth | 6–8% | – | – | 16 | |
| FY2025 | 2023-05-09 | FY25 cost savings target | ~75 | – | – | 4 | |
| 2025-Q4 | 2025-05-06 | Revenue | mid single digit decline | 1,252.4 | – | 22 | |
| FY2024 | 2024-05-06 | Gross margin (GAAP) | modest | – | – | 13 | |
| FY2024 | 2024-05-06 | EBITDA margin | at the upper end of 10 to 30 basis points | – | – | 13 | |
| FY2024 | 2024-05-06 | Like-for-like net revenue growth | 9–11% | – | – | 13 | |
| FY2024 | 2024-05-06 | Free cash flow | 400 | – | – | 13 | |
| FY2024 | 2023-11-08 | Revenue | high single digits to low double digits | 6,118 | – | 10 | |
| FY2024 | 2023-11-07 | EBITDA (adjusted) | 1,080–1,090 | 1,091.1 | 13 | ||
| FY2024 | 2023-11-07 | LFL revenue growth | 9–11% | – | – | 11 | |
| FY2024 | 2023-08-22 | EPS (non-GAAP) | 0.44–0.47 | 0.37 | 13 | ||
| FY2024 | 2023-08-22 | Core LFL growth | 6–8% | – | – | 8 | |
| FY2024 | 2023-05-09 | FY24 cost savings target | ~90 | – | – | 4 |
Coty Stock: Price & Chart
Interactive price chart of Coty stock (TradingView) and the trend of key figures from the core tables; the chart loads only after a click and then connects to TradingView. NadirAlpha methodology
Daily candles with news and earnings markers. Loads only on click.
Coty Event Timeline
This timeline collects the material events of Coty from the original reports: guidance changes, revenue and margin signals, strategy shifts, product and M&A announcements, grouped by quarter. NadirAlpha methodology
2026 · 14 events
Q4 gross margin decreased 140 basis points year-over-year to 60.9%, reflecting lower cost absorption, elevated excess and obsolescence charges, and tariff impact 32
FY27 described as a transition year with reported net revenues expected to decline by low- to mid-single-digit percentage; Coty providing guidance only for Q1 and first-half free cash flow visibility 32 33
Coty announced agreement to sell Gucci Beauty license back to Kering one year ahead of expiration for $400 million plus inventory proceeds, with $250.0 million received July 7, 2026 and $150.0 million due by September 30, 2027 32
“Q3 marked an important step toward restoring consistent performance commensurate with Coty's outstanding assets and capabilities.”
Asset impairment charges of $362.8 million recorded, including $237.1 million goodwill impairment in Consumer Beauty and $125.7 million in trademark impairments for CoverGirl, Sally Hansen, Max Factor, and Bourjois, driving quarterly operating loss of USD 372 million 30
FY26 adjusted EBITDA guidance reinstated at $838-848 million; adjusted EPS (excluding equity swap) of $0.33-$0.35 31
Coty.Curated strategic framework implemented to reduce portfolio complexity, focus on core brands, and identify P&L savings opportunities 31
“I'm truly excited and energized to join Coty at this pivotal moment. In my first month in the role, having visited our largest markets and key sites, it's very clear to me that Coty has many top-notch assets and competitive advantages: highly attractive brands, best-in-class fragrance innovation capabilities, a vertically integrated business model, and a creative, entrepreneurial organization. At the same time, our financial performance over the past year and a half has been disappointing, and our current share price reflects that reality. Both things are true: Coty has outstanding assets and capabilities, yet we have not been delivering at the level we should. To step-change our performance and channel our strengths, we are initiating our "Coty. Curated." strategic framework, encompassing sharper priorities, more focused investments, improved execution, and increased support behind our core businesses. These actions are anchored in consumer demand and a relentless focus on sell-out and market share. In parallel, we are continuing our portfolio review to identify opportunities to unlock shareholder value in both the near and long term, complemented by other value-driving opportunities, such as our recent divestiture of our remaining stake in Wella at the end of CY25, delivering on our commitment. With greater focus and discipline, I believe Coty is well positioned to deliver consistent, profitable growth and realize its full potential.”
Company withdrew prior FY26 guidance for EBITDA and free cash flow due to leadership transition and complex market backdrop 29
Markus Strobel appointed Executive Chairman and Interim CEO effective January 1, 2026, with comprehensive business review underway to enhance performance and competitive positioning 29
Coty sold remaining 25.8% stake in Wella to KKR for $750 million; proceeds used to redeem €500.0 million of 2028 Euro Senior Secured Notes, reducing total debt and financial net debt to nine-year lows 29
Operating cash flow turned positive on a half-year basis (2025-H2: -39.3 to 2026-H1: +USD 624.9 million, aggregated from reported quarters where needed). 129
“As a result, we expect Q2 sales to be at the more favorable end of our previous guidance, with a return to sales and profit growth in the second half of FY26.”
Net revenues decreased 6% to USD 1,577.2 million, driven by 10% unit volume decline, partially offset by 2% positive foreign currency impact and 2% positive price/mix 26
Gross margin declined approximately 100 basis points due to 60 basis points manufacturing/material cost increase and 40 basis points freight cost increase from customs duties 26
Coty initiated comprehensive strategic review of mass color cosmetics business generating approximately $1.2 billion in sales and Brazil operations contributing close to $400 million in FY25 sales 27
Net income turned positive for the first time after 2 negative periods (-68.8 to +USD 67.9 million). 26
2025 · 15 events
Operating income more than halved YoY (546.7 to USD 241.1 million, -56%). 24
“While Q4 was broadly in line with expectations as we set the baseline for a strong launch calendar in FY26, and we expect our organizational changes will start yielding results in the coming year, there is more to do.”
FY26 guidance initiated: H1 net revenue expected to decline in low-single digit percentage versus prior year; H2 expected to return to growth supported by major launches; gross margin pressured by lower sales and tariff impacts estimated at approximately $70.0 million, majority expected in fiscal 2026 25
FY25 full-year net revenues declined 4% reported and 2% LFL to 5,892.9 million; Prestige segment net revenues decreased 1% to $3,820.2 million; Consumer Beauty segment declined 8% to $2,072.7 million 24 25
Operating income more than halved YoY (34.7 to USD 15.5 million, -55%). 132
Fixed Cost Reduction Plan announced April 24, 2025 targeting approximately $80.0 million in cash costs across fiscal 2026 and 2027, alongside new U.S. leadership and updated organizational structure to drive faster execution; total All-In to Win savings target of $500 million across FY25-FY27 23
“And finally, with our brand desirability and equity at the highest level in years, a pipeline of initiatives which is the strongest in 5 years, and our margins, profit, debt and leverage all significantly improved versus four years ago, we have the levers to protect our profitability and cash flow in a variety of macroeconomic scenarios. Coty remains well positioned to succeed and outperform in the coming years.”
Asset impairment charge of $212.8 million on Max Factor, CoverGirl, Bourjois, and Philosophy trademarks drove an operating loss of 280.4 million in Q3, compared to positive operating income in prior quarters 22 23
FY25 guidance updated to reflect high single-digit LFL decline in Q4 sales, translating to approximately 2% LFL decline for the full year 22
“On the other hand, the pressure in pockets of our business which we discussed at length on the last earnings call, namely in China, Travel Retail Asia, Australia and in Consumer Beauty U.S., impacted us even more significantly in Q2. And in our core markets, despite a seemingly strong holiday period, where beauty performed strongly and consumers engaged with the category, this did not translate into improved replenishment orders for Coty as retailers managed their inventory very tightly.”
Net revenues decreased 3% to 1,669.9 million; color cosmetics and mass body care in Brazil declined due to negative market trends and competitive pricing actions 20
Gross margin improved to 66.7% from 65.1%, reflecting manufacturing efficiencies and procurement optimization; adjusted EBITDA increased 7% with margin expansion of 220 basis points 20 21
New beauty license agreement signed with Swarovski for fragrance development and distribution; first offering anticipated in 2026 21
“We will continue to play the full range of our brands and categories to capture growth opportunities and support sustained outperformance.”
Net revenues grew 2% reported and 4.5% LFL to 1,671.5 million, below the prior Q1 estimated pace of 6% LFL; Prestige segment up 5%, Consumer Beauty segment declined 3% 17 18
Gross margin expanded 200 basis points, with 110 basis points from manufacturing efficiency and 80 basis points from decreased excess and obsolescence costs 18
FY25 guidance reiterated with adjusted EBITDA growth near lower end of +9-11% target and cost savings acceleration to over $120 million 19
2024 · 16 events
“we have once again delivered double digit growth in our LFL sales and adjusted EPS, excluding the swap impact. This marks the third consecutive year of double digit growth in both metrics.”
FY24 reported and adjusted gross margin improved 50 basis points year-over-year to 64.4%, driven by supply chain savings and pricing actions 16
FY25 guidance initiated: 6-8% LFL revenue growth, adjusted EBITDA of $1,186-1,208 million representing 9-11% growth, and adjusted EPS of $0.54-0.57 excluding equity swap 16
Operating income more than halved YoY (129.0 to USD 34.7 million, -73%). 116
“Our Q3 results reinforce Coty's established track record of delivering results ahead of the beauty market and ahead of expectations, and once again illustrate that we are executing on our imperative to drive balanced portfolio growth.”
Q3 net revenues of 1,385.6 million grew 8% reported and 10% LFL, exceeding prior H2 guidance of +6-8% LFL, with Global Travel Retail growing over 20% and e-commerce nearly 20% 13
Reported gross margin expanded 190 basis points to 64.8% in Q3, driven by premiumization, pricing, easing inflation, and supply chain productivity savings 13
FY24 guidance raised for the third time; Coty now expects the high end of +9-11% LFL revenue growth, adjusted EBITDA margin expansion at the upper end, and adjusted EPS at the high end of $0.44-$0.47 13
“Importantly, strong momentum across our other key fragrance launches including Boss Bottled Elixir, Gucci Flora Gorgeous Magnolia, and additions to the Chloé Atelier des Fleurs collection, drove each of our Top 7 fragrance brands to grow at a double-digit percentage in the first half FY24.”
Q2 net revenues of 1,727.6 million grew 13% reported and 11% LFL, moderating from Q1's 18% LFL, though H1 cumulative growth exceeded guidance of +11-13% LFL 11
Gross margin declined 40 basis points to 65.1% in Q2 due to higher excess and obsolescence tied to Prestige inventory build, inflation, and non-recurring prior year benefits 11
Announced new long-term license agreement with Marni for fragrance and beauty collections, with license extending beyond 2040 11
Operating cash flow turned positive on a half-year basis (2023-H2: -19.7 to 2024-H1: +USD 608.1 million, aggregated from reported quarters where needed). 121
“In short, on the eve of our 120th anniversary, Coty has returned to our Parisian roots, now providing both U.S. and European investors with the perfect opportunity to join our accelerating growth trajectory and success.”
Net revenues of 1,641.4 million grew 18% reported and LFL, driven by 23% growth in Prestige and 10% growth in Consumer Beauty with all regions posting double-digit percentage growth 9
FY24 LFL revenue growth guidance raised to +9-11% from +8-10%; FY24 adjusted EBITDA guidance raised to $1,080-1,090 million from $1,075-1,085 million 9
Renewed long-term license agreement with adidas for personal care and wellness; expanded and extended long-term Marc Jacobs license to include Beauty over 15 years 9
Coty Business Model
What Coty does and how the company earns its money, written AI-editorially from the original reports alone, without any assessment of our own. NadirAlpha methodology
Coty is a global beauty company operating through two segments: Prestige, which markets fragrances, color cosmetics and skincare products under licensed brand names such as Burberry, Calvin Klein, Hugo Boss, Davidoff and Marc Jacobs through specialty retailers, department stores and travel retail; and Consumer Beauty, which sells mass-market fragrances, color cosmetics and skincare under owned brands including CoverGirl, Sally Hansen, Rimmel and Bourjois primarily through drug stores, supermarkets and mass merchants. Revenue is generated through the sale of finished beauty products, with the Prestige segment focused on premium-priced, selectively distributed goods under long-term license agreements, while Consumer Beauty targets broad retail accessibility under owned brand portfolios. Coty's licensing model creates both commercial opportunity and concentration risk, as demonstrated by the early termination of the Gucci Beauty license in July 2026 and the planned exit from the Gucci fragrance license, which is expected to impact fiscal 2028.
Coty Stock: Share-Price Drivers
What determines the business trajectory of Coty according to management, summarised from the reports up to Q4 FY2026. NadirAlpha methodology
Coty's Prestige segment carries the larger share of group revenue and remains the focus of new launches, while overall group sales and operating profit have turned lower, with operating income at USD -42.7 million in the latest quarter and net debt still around USD 2,871.7 million 33 132
Coty continues to feed its Prestige line with releases such as BOSS Bottled Beyond 29 and the planned Calvin Klein Euphoria Elixirs for Spring 2026 31; the Prestige segment remains the company's largest by revenue 33
Coty's Consumer Beauty segment carries the mass makeup brands, and group revenue declined to USD 1,269.2 million in the latest quarter from USD 1,678.6 million two quarters earlier, with the change flags showing decelerating growth 33 132
Coty's net debt moved lower across fiscal 2026, from USD 3,760 million to USD 2,871.7 million, supported by refinancing steps including the 2031 Senior Secured Notes issuance 28 132
Coty is running a Fixed Cost Reduction Plan aimed at lowering its cost base, while adjusted operating income held positive at USD 39.5 million even as reported operating income was negative 33 132
Coty plans a Marc Jacobs Beauty makeup debut and entry into Sephora from September 2026 32, and a Kylie Cosmetics Mood Stones fragrance collection for FY27 32; traction is not yet evidenced in reported results
On the prior regional view, Coty's Asia Pacific sales were down 7% and the Americas down 3%, while EMEA rose 1% 24
Sector trend: In the beauty and fragrance sector, Coty's reported segment margins and group demand are trending lower, with revenue and reported operating income softening and growth decelerating, while adjusted profitability and free cash flow remained positive in the latest quarter 33 132. Prestige fragrance demand is holding up better than mass Consumer Beauty, where volumes and margin are under more pressure 24.
Coty Revenue by Type (as of 2026-Q4 · USD million · 5/5)
The segments of Coty in the company's own definition, each row with its basis (3, 6 or 12 months), rows in grey are no longer reported separately. NadirAlpha methodology
| Segment | Since | Revenue | Growth | Margin | Source |
|---|---|---|---|---|---|
| Period FY2026 (12M?) | |||||
| Prestige | 2022-Q2 | 3,805.8 | – | 11.7% | 33 |
| Consumer Beauty | 2022-Q2 | 2,000.8 | – | 22.1% | 33 |
| Period FY2025 (12M) | |||||
| EMEA | 2025-Q1 | 2,811.8 | 1% | – | 24 |
| Americas | 2025-Q1 | 2,373 | -3% | – | 24 |
| Asia Pacific | 2025-Q1 | 708.1 | -7% | – | 24 |
Coty Products & announcements (45/101 active+recent)
What Coty launched, had approved or announced, from the filings up to Q4 FY2026, each row with the date of first mention. NadirAlpha methodology
Status: PlannedLaunched
| Product/Line | Since | Status | Source |
|---|---|---|---|
| 2027 | |||
| Swarovksi fragrances debut | 2027 | 33 | |
| 2026 | |||
| Kylie Skin Tint launch | 2026-09 | 30 | |
| Kylie Hybrid Blush launch | 2026-09 | 30 | |
| Calvin Klein Euphoria Elixir launch (2×) | 2026-09 | 31 | |
| Gucci Bloom Ambrosia D'oro | 2026-06 | 28 | |
| Mass fragrance launches in value segments | 2026-03 | 26 | |
| Marni fragrance | 2026 | 27 | |
| Etro brand ultra-premium fragrances | 2026 | 27 | |
| Chloé Atelier des Fleurs - Les Essences Méditerranéennes launch | 2026 | 31 | |
| 2025 | |||
| New innovations under key mass fragrance brands | 2025-09 | 22 | |
| New fragrance lines co-developed with key retailers | 2025-09 | 22 | |
| New cosmetics technologies in mascara and nail | 2025-09 | 22 | |
| New brand launch on Amazon in fall | 2025-09 | 22 | |
| Extension of major brand into U.S. | 2025-09 | 22 | |
| Expansions into ultra-premium fragrances, body mists, and pen sprays | 2025-09 | 22 | |
| Body mists and adjacencies expansions | 2025-09 | 22 | |
| Blockbuster launch in 2H FY26 (2×) | 2025-09 | 22 | |
| adidas Vibes Fragrance Collection Launch | 2025-06 | 21 | |
| Marc Jacobs makeup debut (7×) | 2025-06 | 32 | |
| Lancaster Golden Lift skincare (2×) | 2025-06 | 21 | |
| Etro Beauty License Products Launch | 2025-06 | 21 | |
| Ligne Princiere European expansion | 2025-03 | 19 | |
| Kylie Cosmetics fragrance mist | 2025-03 | 27 | |
| Jawhara Arabian fragrance collection | 2025-03 | 27 | |
| adidas fragrance mist (9×) | 2025 | 27 | |
| Vera Wang new mass fragrance innovations | 2025 | 24 | |
| Rimmel Oh My Gloss! Butter Me Up | 2025 | 24 | |
| Rimmel Multi-Tasker Jelly Crush | 2025 | 24 | |
| Origen collection launches at Walmart | 2025 | 24 | |
| Nautica new innovations and scenting adjacencies | 2025 | 24 | |
| Marc Jacobs on Amazon Premium Beauty Store (2×) | 2025 | 24 | |
| Hugo Boss brand distribution extension into U.S. market (2×) | 2025 | 27 | |
| Fixed Cost Reduction Plan | 2025 | 33 | |
| Etro Nectar repromotion | 2025 | 27 | |
| CoverGirl Yummy Blur lipstick | 2025 | 24 | |
| CoverGirl TruBlend Skin Enhancer Balms | 2025 | 24 | |
| Bruno banani new mass fragrance innovations | 2025 | 24 | |
| 2024 | |||
| Cosmic Kylie Jenner (4x) | 2024-03 | 19 | |
| Marni beauty license | 2024-02 | 21 | |
| Marc Jacobs Daisy Wild (2x) | 2024 | 21 | |
| CoverGirl Simply Ageless Skin Perfector Essence (2x) | 2024 | 19 | |
| 2023 | |||
| Burberry Goddess (8x) | 2023 | 19 | |
| 2022 | |||
| Boss Bottled Parfum (7x) | 2022 | 29 | |
| Undated | |||
| Rimmel Thrill Seeker Extreme mascara | FY24 | 19 | |
| CoverGirl Eye Enhancer 3D Mascara | FY25 | 19 | |
| 2025 | |||
| La Maison Orveda New York City (3×) | 2025-06 | 19 | |
| 2024 | |||
| FY24 Sustainability Report | 2024-11 | 19 | |
| Scientific Advisory Board | 2024-09 | 19 | |
| Rimmel Manhattan Lasting Finish foundation and Thrill Seeker mascara | 2024-06 | 12 | |
| Rimmel Wonder'Bond mascara | 2024-03 | 13 | |
| Nautica fragrance distribution expansion in United States | 2024-03 | 10 | |
| David Beckham Instinct re-launch | 2024-03 | 15 | |
| Chloe Signature Intense launch (2x) | 2024-03 | 16 | |
| Bruno Banani Magnetic Man launch (2x) | 2024-03 | 12 | |
| Share buyback program first tranche (27 million shares) | 2024-02 | 13 | |
| Infiniment Coty Paris ultra-premium fragrance collection | 2024-02 | 13 | |
| Refillable format expansion including Burberry Goddess and Cosmic Kylie Jenner | 2024 | 15 | |
| Marc Jacobs prestige cosmetics line launch | 2024 | 8 | |
| Infiniment Coty Paris carbon-captured ethanol production | 2024 | 15 | |
| Forward repurchase transactions for potential $200 million repurchase in 2024 and $196 million in 2025 | 2024 | 7 | |
| 2023 | |||
| Orveda innovation in China | 2023-12 | 5 | |
| Orveda Omnipotent Serum launch (2x) | 2023-12 | 16 | |
| Lancaster China launch | 2023-12 | 5 | |
| Sally Hansen Perfect Manicure collection | 2023-09 | 4 | |
| Prestige cosmetics expansion | 2023-09 | 3 | |
| Lancaster Ligne Princière skincare line launch | 2023-09 | 4 | |
| Hugo Boss fragrances expansion | 2023-09 | 3 | |
| China market expansion with prestige products | 2023-09 | 3 | |
| Burberry Hero and Her fragrances | 2023-09 | 4 | |
| Burberry Her Elixir De Parfum | 2023-09 | 4 | |
| Lancaster Ligne Princiere skincare launch in China | 2023-06 | 2 | |
| Philosophy Dose of Wisdom Bouncy Skin Reactivating Serum | 2023-04 | 4 | |
| Philosophy brand relaunch with dermatologic wisdom principle | 2023-04 | 4 | |
| Gucci Alchemist's Garden Where My Heart Beats fragrance | 2023-04 | 4 | |
| adidas Active Skin & Mind range launch | 2023 | 8 | |
| Yummy Gloss CoverGirl launch (2x) | 2023 | 8 | |
| Rimmel Thrillseeker mascara launch | 2023 | 11 | |
| Rimmel Kind & Free launch | 2023 | 8 | |
| Prestige fragrance launches including Burberry Hero, Burberry Her, Calvin Klein, Hugo Boss Boss Bottled, Gucci Flora, Marc Jacobs Daisy | 2023 | 7 | |
| Max Factor Miracle Pure foundation launch | 2023 | 8 | |
| Lancaster and Philosophy prestige skincare launches | 2023 | 8 | |
| Infiniment Coty Paris fragrance line launch (2x) | 2023 | 5 | |
| Hugo Boss license extension | 2023 | 8 | |
| Hugo Boss Parfum launch | 2023 | 8 | |
| Gucci Flora prestige fragrance growth | 2023 | 7 | |
| Davidoff license extension | 2023 | 8 | |
| CoverGirl Simply Ageless line extension | 2023 | 8 | |
| Chloe Atelier des Fleurs (3x) | 2023 | 9 | |
| Burberry Hero EDP and Her Elixir launches | 2023 | 8 | |
| Bourjois Healthy Mix foundation launch | 2023 | 8 | |
| 2022 | |||
| Gucci Flora Gorgeous Orchid launch (7x) | 2022 | 4 | |
| Burberry Hero EDP launch | 2022 | 2 | |
| Undated | |||
| adidas Vibes mass fragrance line | FY25 | 16 | |
| Philosophy skincare return to growth | FY24 | 16 | |
| Lancaster skincare growth | FY24 | 16 | |
| Kylie Cosmetics new locations globally | FY24 | 16 | |
| Kylie Cosmetics Mood Stones fragrance collection launch | FY27 | 32 | |
| CoverGirl TruBlend Sun & Sculpt Bronzing Glow Serum launch | FY27 | 32 | |
| Calvin Klein key female fragrance initiative launch | coming weeks | 29 | |
| Blockbuster launch under flagship Coty brand | 2H26 | 24 | |
Coty Transactions & Events (31)
31 transactions and events of Coty from the original reports, financing measures and management changes are not listed here, cancelled items in grey. NadirAlpha methodology
Acquisitions by Coty
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2026 | |||
| Strategic review of Consumer Beauty business including potential divestitures and partnerships | 2026-03 | Completed | 26 |
| 2025 | |||
| Strategic review of consumer beauty business including mass color cosmetics and Brazil business | 2025 | Completed | 33 |
| 2024 | |||
| Swarovski fragrance (5×) | 2024-12 | Completed | 16 |
| Mexx Consumer Beauty license extension (2×) | 2024-02 | Completed | 11 |
| 2023 | |||
| Forward Repurchase Contracts (November 2023) | 2023-11 | Completed | 30 |
| Euronext Paris listing of 33 million shares at $10.80 or €10.28 | 2023-09 | Completed | 9 |
| Marc Jacobs license expansion and extension (2×) | 2023 | Completed | 9 |
| Jil Sander license extension (3×) | 2023 | Completed | 4 |
| 2022 | |||
| Forward Repurchase Contracts (June 2022) (2×) | 2022-06 | Completed | 30 |
Divestitures and exits by Coty
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2028 | |||
| Gucci fragrance license exit | 2028 | Divested | 33 |
| 2026 | |||
| Gucci Beauty license exit agreement with Kering | 2026-07 | Divested | 32 |
| 2025 | |||
| Wella stake monetization | 2025-12 | Divested | 32 |
| Sale of investment in Wella Company | 2025-12 | Divested | 29 |
| SKKN brand sale to SKIMS | 2025-03 | Divested | 22 |
| Wella divestiture (remaining 25.8% stake to KKR) | 2025 | Divested | 29 |
| 2024 | |||
| Lacoste license termination and market exit | 2024-06 | Divested | 22 |
| Sale of remaining Wella stake (2×) | 2024-03 | Divested | 30 |
| 2023 | |||
| Russia market exit | 2023-09 | Divested | 26 |
| Wella equity interest sale (6×) | 2023-07 | Divested | 7 |
| Wella divestiture agreement | 2023-07 | Divested | 10 |
| Russia business wind down | 2023 | Divested | 23 |
| Bottega Veneta licensing arrangement ending | 2023 | Divested | 15 |
| 2022 | |||
| Lacoste license divestiture | 2022-12 | Divested | 18 |
Partnerships and contracts of Coty
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2025 | |||
| KKW Collaboration Agreement | 2025 | Agreement | 33 |
| 2024 | |||
| Etro fragrance and home scent license agreement | 2024-02 | Agreement | 13 |
| Max Factor UK partnership with UNICEF Skills4Girls program | 2024 | Agreement | 15 |
| 2023 | |||
| adidas partnership strengthening | 2023 | Agreement | 8 |
| 2022 | |||
| HUGO BOSS license agreement renewal beyond 2035 | 2022-12 | Agreement | 2 |
| 2021 | |||
| Kim Kardashian strategic partnership | 2021 | Agreement | 15 |
| 2020 | |||
| Kylie Cosmetics by Kylie Jenner partnership | 2020 | Agreement | 15 |
Regulation and legislation at Coty
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| 2023 | |||
| adidas license renewal | 2023-08 | Regulation | 9 |
Coty Risks (89 since the annual report of 2026-08-20, 357 tracked in total)
Which risks Coty has named since the annual report, company-specific first, generic standard risks in the expandable part; first mention refers to the document base from 2023. NadirAlpha methodology
Category: CustomersRegulatorySupply chainCompetitionGeopoliticsFinancialMarketCyberESGMacroLegalTechnologyPeopleprodukt
| Risk | Category | Last reported |
|---|---|---|
| Coty: first mention in 8-K-EX99.1 earnings release of 2026-08-19 (2026-Q4), source 32 | ||
| Sell-out performance below market levels in both divisions | = | |
| Strategic review of Consumer Beauty business ongoing through CY26 | = | |
| Supply chain cost under-absorption from lower volumes | = | |
| Promotional environment impacting pricing and margin | = | |
| Coty: first mention in 10-Q quarterly report of 2026-05-05 (2026-Q3), source 30 | ||
| Estimated 1% headwind to Q4 sales from Middle East conflict | 2026-Q4 2026-08-19 32 | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2024-05-06 (2024-Q3), source 13 | ||
| Financial leverage ratio of 3.4x; significant debt reduction focus ongoing | 2026-Q4 2026-08-19 32 | |
| Coty: first mention in 10-Q quarterly report of 2023-02-08 (2023-Q2), source 1 | ||
| Foreign exchange headwinds and volatility affecting international sales | 2026-Q4 2026-08-19 32 | |
| Coty: first mention in 10-K annual report of 2026-08-20 (FY2026), source 33 | ||
| Advanced cyber attacks including AI-enabled threats increasingly difficult to detect and prevent; insider actors could cause data leakage. | = | |
| Reliance on third-party IT providers not fully controlled with data security and privacy risks. | = | |
| Dependence on reputations of brand partners, influencers and licensors outside company control. | = | |
| Reputational risks from product quality issues, recall failures or misconduct by executives or influencers. | = | |
| Risk of failing to achieve announced sustainability goals damaging reputation and stakeholder confidence. | = | |
| Rating downgrade on July 9, 2026 resulted in reinstatement of covenants and collateral requirements on Senior Secured Notes | = | |
| €500.0 million Euro Senior Secured Notes due May 2027 require refinancing subject to market conditions | = | |
| Net loss of $201.9 million on sale of equity investments and $133.0 million losses on forward repurchase contracts | = | |
| High debt levels with ongoing deleveraging objectives potentially constraining acquisition capacity. | = | |
| War in Ukraine and Middle East, border disputes and geopolitical tensions affecting operations. | = | |
| JAB Beauty B.V. owns approximately 54% of Class A Common Stock enabling control over director election and significant corporate decisions potentially conflicting with other shareholders. | = | |
| Inflationary pressures and cost volatility in essential oils, chemicals, glass and packaging components. | = | |
| Reliance on limited suppliers for critical raw materials and potential supply constraints. | = | |
| Price inflation for labor, materials and services exacerbated by energy and commodity volatility. | = | |
| Additional U.S. and international tariffs, trade barriers, and retaliatory measures could increase costs and reduce sales; significant uncertainty regarding future trade policies. | = | |
| Highly competitive color cosmetics market in United States and European markets negatively impacting revenue | = | |
| Gucci Beauty license early termination effective June 30, 2027 requiring restructuring and transition. | = | |
| Tax Matters Agreement with P&G requires indemnification if Distribution or P&G Beauty Business acquisition fails to qualify for intended tax treatment. | = | |
| Counterfeit products and grey market distribution diluting brand value and potentially breaching licenses. | = | |
| Ongoing uncertainty in U.S. trade policies and tariff framework creating supply chain and cost pressures | = | |
| AI use expansion presents risks of inaccurate outputs, unauthorized disclosure of confidential information, IP infringement; controls may be ineffective. | = | |
| Declining sales in color cosmetics and prestige fragrance categories despite innovation efforts | = | |
| Changes in U.S. and foreign tax laws, global minimum taxes, and multinational tax focus could increase tax liabilities and compliance costs. | = | |
| Wars in Ukraine and Middle East, terrorism, and armed conflicts disrupt supply chains, increase transportation costs, and reduce consumer spending in affected regions. | = | |
| Price inflation in labor, materials, services, and energy exacerbated by geopolitical events could adversely affect profitability if price increases cannot be passed through. | = | |
| Broader macroeconomic disruptions could negatively impact trademark valuations | = | |
| Shift toward e-commerce and direct-to-consumer channels requiring significant investment and capabilities. | = | |
| Increasing environmental and sustainability regulatory requirements including GHG emissions and deforestation. | = | |
| Advances in AI technology creating intellectual property challenges not adequately covered by existing law. | = | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2026-05-05 (2026-Q3), source 31 | ||
| Extensive reliance on trademark licenses with renewal risks and termination conditions. | FY2026 2026-08-20 33 | |
| Coty: first mention in 10-Q quarterly report of 2026-05-05 (2026-Q3), source 30 | ||
| Adverse changes in revenue growth rates or discount rates could trigger additional impairments | FY2026 2026-08-20 33 | |
| Coty: first mention in 10-Q quarterly report of 2026-02-05 (2026-Q2), source 28 | ||
| Brazilian tax assessment appeals require surety bonds of R$1,088.9 million (approximately $198.7 million) | = | |
| Coty: first mention in 10-Q quarterly report of 2025-11-05 (2026-Q1), source 26 | ||
| Complex and evolving laws regarding data privacy, AI, product content, labeling, environmental, climate, labor, and trade compliance requiring ongoing operational adjustments. | FY2026 2026-08-20 33 | |
| Coty: first mention in 10-K annual report of 2025-08-21 (FY2025), source 25 | ||
| Seasonal beauty industry cash flows may affect ability to satisfy debt service obligations; refinancing may require higher interest rates and more onerous covenants. | FY2026 2026-08-20 33 | |
| Fraud or misconduct by employees or third parties could result in legal or regulatory action and reputational harm | = | |
| Harassment or discrimination claims could result in liabilities litigation and reputational damage | = | |
| Loss on KKW Collaboration Agreement termination of $71.0 million in fiscal 2025. | = | |
| If Distribution or acquisition of P&G Beauty Business fails to qualify for intended tax treatment indemnification could be substantial | = | |
| Pending tax assessment matters in Brazil relating to sales tax credits could result in unfavorable rulings | = | |
| Deterioration in global financial markets could make financing difficult or more expensive; financial institution insolvency could impair hedging or access to deposits. | FY2026 2026-08-20 33 | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2025-08-20 (FY2025), source 24 | ||
| Early termination of KKW Collaboration Agreement resulted in significant losses | = | |
| Coty: first mention in 10-Q quarterly report of 2025-05-07 (2025-Q3), source 23 | ||
| Relationship with JAB Beauty B.V. as majority stockholder and its affiliates with potential conflicts of interest or litigation risks. | = | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2025-05-06 (2025-Q3), source 22 | ||
| Tariff increases estimated to impact operating results by approximately $32.7 million after mitigation through first quarter fiscal 2027 | FY2026 2026-08-20 33 | |
| Coty: first mention in 10-Q quarterly report of 2025-02-10 (2025-Q2), source 20 | ||
| Sales declines in mass fragrance and color cosmetics in US and Europe | FY2026 2026-08-20 33 | |
| Coty: first mention in 10-Q quarterly report of 2024-11-06 (2025-Q1), source 18 | ||
| Product liability cases including asbestos and talc litigation with potential indemnity gaps | = | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2024-08-20 (FY2024), source 16 | ||
| Rapid changes in consumer preferences and product life cycles requiring continuous innovation. | FY2026 2026-08-20 33 | |
| Ongoing legal and compliance risks including product liability cases and talc-related litigation | 2026-Q3 2026-05-05 30 | |
| Asset impairment charges indicate trademark valuation challenges | FY2025 2025-08-20 24 | |
| Coty: first mention in 10-K annual report of 2024-08-20 (FY2024), source 15 | ||
| Success dependent on key personnel including Interim CEO and management team retention. | FY2026 2026-08-20 33 | |
| Regulatory requirements for product claims substantiation and safety compliance across jurisdictions. | FY2026 2026-08-20 33 | |
| Operations in 37 countries expose company to foreign laws, corruption risks, sanctions compliance, and inadequate compliance program effectiveness. | FY2026 2026-08-20 33 | |
| Subject to legal proceedings and talc-related litigation alleging bodily injury | FY2025 2025-08-21 25 | |
| Significant exposure to euro, pound, yuan, peso, zloty, real, and dollar exchange rate fluctuations affecting reported earnings and operating costs. | FY2026 2026-08-20 33 | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2024-05-06 (2024-Q3), source 13 | ||
| Global supply chain disruptions impacting manufacturing and distribution capacity. | FY2026 2026-08-20 33 | |
| Coty: first mention in 10-Q quarterly report of 2024-02-08 (2024-Q2), source 12 | ||
| Tariff impacts on prestige fragrances from Barcelona plant and sourcing of components and materials from China | FY2026 2026-08-20 33 | |
| Dependence on certain licenses especially in fragrance category; ability to renew expiring licenses on favorable terms uncertain | 2026-Q1 2025-11-05 27 | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2023-08-22 (2023-Q4), source 8 | ||
| Emerging AI technology may generate IP developments inadequately protected by existing laws | FY2025 2025-08-21 25 | |
| Coty: first mention in 10-K annual report of 2023-08-22 (FY2023), source 7 | ||
| Risk of employee fraud, misconduct, noncompliance, sexual harassment, discrimination, and misuse of confidential information. | FY2026 2026-08-20 33 | |
| Controlled company status exempts company from NYSE independence requirements for board and committees reducing shareholder protections. | FY2026 2026-08-20 33 | |
| Substantial indebtedness with restrictive covenants limits operational flexibility; debt burden increases vulnerability to economic conditions and interest rate risk. | FY2026 2026-08-20 33 | |
| Significant impairment charges recorded (212.8 million FY2025, 362.8 million FY2026) on goodwill and trademarks. | FY2026 2026-08-20 33 | |
| Stock repurchase program and forward repurchase contracts expose company to stock price volatility; true-up payment obligations declined share price. | FY2026 2026-08-20 33 | |
| Global operations in 122 countries expose company to geopolitical instability, military conflicts, sanctions, and trade restrictions affecting market access. | FY2026 2026-08-20 33 | |
| Overestimation or underestimation of demand could result in excess inventory writedowns or inadequate inventory hindering ability to meet demand. | FY2026 2026-08-20 33 | |
| Exposure to currency exchange rate fluctuations across multiple international operations. | FY2026 2026-08-20 33 | |
| Restructuring and workforce changes increase risk of employment-related claims including discrimination, harassment, wrongful termination, and wage violations. | FY2026 2026-08-20 33 | |
| Brazilian subsidiaries subject to ongoing tax assessments with surety bonds of R$1,117.9 million approximately $216.1 million outstanding | FY2026 2026-08-20 33 | |
| Talc-related litigation alleging bodily injury and product liability could result in substantial damages | FY2025 2025-08-21 25 | |
| Brand licenses may be terminated if conditions not met; renewal not guaranteed on favorable terms | FY2025 2025-08-21 25 | |
| Dual-listing on NYSE and Euronext Paris may dilute liquidity, limit trading market development, and expose stock to euro-dollar currency fluctuations. | FY2026 2026-08-20 33 | |
| General economic downturn, recession, inflation, or weak consumer confidence could reduce discretionary spending on beauty products and retailer financial difficulties. | FY2026 2026-08-20 33 | |
| Significant decline in consumer confidence and spending could require future impairment charges | FY2026 2026-08-20 33 | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2023-05-09 (2023-Q3), source 4 | ||
| Dependence on information technology systems with exposure to cyber attacks and data breaches. | FY2026 2026-08-20 33 | |
| Increased consolidation in retail with fewer key retailers controlling larger share of locations and distribution. | FY2026 2026-08-20 33 | |
| Competitive labor market, increased employee turnover, and labor shortages in extended supply chain; loss of key personnel could adversely affect business. | FY2026 2026-08-20 33 | |
| Highly competitive beauty industry with emerging niche brands and e-commerce disruptors challenging traditional players. | FY2026 2026-08-20 33 | |
| Coty: first mention in 10-Q quarterly report of 2023-05-09 (2023-Q3), source 3 | ||
| Brazilian tax assessments subject to appeal; surety bonds of R$1,094.8 million (approximately $208.4) posted as of March 31, 2026 | 2026-Q3 2026-05-05 30 | |
| Coty: first mention in 8-K-EX99.1 earnings release of 2023-02-08 (2023-Q2), source 2 | ||
| Company exited Russian market resulting in tax charges and business realignment costs | FY2026 2026-08-20 33 | |
| Coty: first mention in 10-Q quarterly report of 2023-02-08 (2023-Q2), source 1 | ||
| Variable interest rate exposure on revolving credit facility subject to changes in market rates | FY2026 2026-08-20 33 | |
| Significant exposure to retail customer inventory levels and purchasing patterns affecting seasonal cash flows | FY2026 2026-08-20 33 | |
| Substantial talc-related litigation alleging asbestos and mesothelioma; settlement values and costs have increased substantially and expected to continue increasing. | FY2026 2026-08-20 33 | |
| Brazilian tax assessments with surety bonds of approximately $172.0 million outstanding. | FY2025 2025-08-21 25 | |
Coty Reported KPIs (as disclosed) (328)
NadirAlpha collects 328 reported KPIs of Coty from the filings up to Q4 FY2026; the definition comes from the company, period and source are stated at every value. NadirAlpha methodology
| KPI | Value / change | Source |
|---|---|---|
| Coty, published 2026-08-20, period FY2026 | ||
| third party manufactured pct | approximately 19 | 33 |
| prestige top seven brands revenue pct | approximately 85 | 33 |
| prestige segment revenue pct | approximately 66 | 33 |
| owned brand products revenue pct | 48 | 33 |
| net debt to adjusted ebitda target | 2x | 33 |
| manufactured and packaged pct | approximately 81 | 33 |
| exclusive license products revenue pct | 37 | 33 |
| countries and territories | approximately 122 | 33 |
| brand licenses | 22 | 33 |
| average license duration | approximately 24 | 33 |
| adjusted operating income margin | 10.8% | 33 |
| adjusted ebitda margin | 14.6% | 33 |
| Coty, published 2026-08-19, period 2026-Q4 | ||
| Total debt to net loss ratio | 5.2x | 32 |
| Total debt | 3,088.2 | 32 |
| Prestige net revenues | 771.8 | 32 |
| Financial net debt | 2,912.1 | 32 |
| Financial leverage ratio | 3.4x | 32 |
| Consumer Beauty net revenues | 497.4 | 32 |
| Cash flow from operations | 116.0 | 32 |
| Adjusted Operating Income TTM | 626.7 | 32 |
| Adjusted Operating Income Q4 Jun | 39.5 | 32 |
| Adjusted Operating Income Q3 Mar | 72.4 | 32 |
| Adjusted Operating Income Q2 Dec | 274.3 | 32 |
| Adjusted Operating Income | 240.5 | 32 |
| Adjusted Depreciation TTM | 220.2 | 32 |
| Coty, published 2026-05-05, period 2026-Q3 | ||
| Tariff costs reflected 9M | 23.0 | 30 |
| Net revenue Q3 | 1,281.6 | 30 |
| Net revenue 9M | 4,537.4 | 30 |
| Gross margin Q3 | 61.8% | 30 |
| Gross margin 9M | 63.5% | 30 |
| Estimated tariff costs | 32.0 | 30 |
| Adjusted operating income margin Q3 | 5.6% | 30 |
| Adjusted operating income margin 9M | 12.9% | 30 |
| Adjusted EBITDA margin Q3 | 9.9% | 30 |
| Adjusted EBITDA margin 9M | 16.6% | 30 |
| Total debt to net income ratio | 6.2x | 31 |
| Total debt | 3,216.2 | 31 |
| Prestige segment - reported operating income | 58.4 | 31 |
| Prestige net revenue | 830.9 | 31 |
| Operating cash flow | 421.8 | 31 |
| Net debt to Adjusted EBITDA target | 2x | 30 |
| Financial net debt | 2,959.1 | 31 |
| Financial leverage ratio | 3.4x | 31 |
| Consumer Beauty segment - reported operating loss | (423.3) | 31 |
| Consumer Beauty net revenue | 450.7 | 31 |
| Coty, published 2026-02-05, period 2026-Q2 | ||
| Total debt | 3,038.1 | 29 |
| Tariff impact | 5.0 | 28 |
| Tariff impact | 14.0 | 28 |
| Net loss on sale of Wella | 201.9 | 28 |
| Net debt | 2,601.4 | 29 |
| Free cash flow Q2 | 513.1 | 29 |
| Free cash flow H1 | 524.3 | 29 |
| Fixed cost reduction life to date | 15.0 | 28 |
| Financial leverage | 2.7x | 29 |
| Estimated full year tariff impact | 33.0 | 28 |
| Cash from operations Q2 | 559.7 | 29 |
| Cash from operations H1 | 624.9 | 29 |
| Wella equity sale proceeds | $750.0 million | 28 |
| Undrawn letters of credit June 30 | $3.1 | 28 |
| Undrawn letters of credit December 31 | $4.1 | 28 |
| Total Debt | 3,038.1 | 29 |
| Tariff costs in first half of | $14.0 | 28 |
| Tariff costs in | $5.0 | 28 |
| Tariff costs in | $28.0 | 28 |
| Tariff cost impact through | $33.0 | 28 |
| Surety bonds Brazilian tax assessments USD equivalent | $198.7 | 28 |
| Surety bonds Brazilian tax assessments | R$1,088.9 million | 28 |
| Net cash used in financing activities December 31 | $(1,106.5) | 28 |
| Net cash used in financing activities December 31 | $(461.3) | 28 |
| Net cash provided by (used in) investing activities December 31 | $658.7 | 28 |
| Net cash provided by (used in) investing activities December 31 | $(108.2) | 28 |
| Net amount factored June 30 | $211.8 | 28 |
| Net amount factored December 31 | $229.8 | 28 |
| June 2022 forward repurchase contracts settled shares | 27.0 million | 28 |
| Hedge valuation adjustments November | $13.7 | 28 |
| Hedge valuation adjustments December | $10.1 | 28 |
| Hedge valuation adjustments August | $53.9 | 28 |
| Forward repurchase contracts November | $294.0 | 28 |
| Forward repurchase contracts June | $200.0 | 28 |
| Forward repurchase contracts December | $196.0 | 28 |
| Fixed Cost Reduction Plan cash costs life-to-date | $15.0 | 28 |
| Fixed Cost Reduction Plan cash costs | $80.0 | 28 |
| Financial Net Debt | 2,601.4 | 29 |
| Cash costs for forward repurchase contracts fiscal year to date | $85.6 | 28 |
| Cash and cash equivalents | 436.7 | 29 |
| Bank guarantees June 30 | $16.0 | 28 |
| Bank guarantees December 31 | $15.8 | 28 |
| 2031 Senior Secured Notes net proceeds | $888.0 | 28 |
| 2031 Senior Secured Notes issued | $900.0 | 28 |
| 2028 Euro Senior Secured Notes redemption premium USD equivalent | $16.9 | 28 |
| 2028 Euro Senior Secured Notes redemption premium | €14.4 million | 28 |
| 2028 Euro Senior Secured Notes redeemed USD equivalent | $588.9 | 28 |
| 2028 Euro Senior Secured Notes redeemed | €500.0 million | 28 |
| 2026 Euro Senior Secured Notes redeemed USD equivalent | $526.8 | 28 |
| 2026 Euro Senior Secured Notes redeemed | €450.0 million | 28 |
| 2026 Dollar Senior Secured Notes redeemed | $350.0 | 28 |
| Coty, published 2025-11-05, period 2026-Q1 | ||
| Wella stake value | 1,003.0 | 27 |
| Wella retained stake | 25.8% | 27 |
| Ultra-premium collections growth | 17% | 27 |
| US Prestige fragrance sell-out growth | mid-to-high single digit percentage | 27 |
| Total debt to net income ratio | 11.1x | 27 |
| Total debt | 4,069.3 | 27 |
| Total debt | 4,069.3 | 27 |
| Tariff costs impact through Q1 fiscal | 35.0 | 26 |
| Selling, general and administrative expenses | 793.5 | 26 |
| Prestige segment net revenues | 1069.5 | 26 |
| Prestige segment net revenue | 1,069.5 | 27 |
| Prestige segment adjusted operating income margin | 22.3% | 26 |
| Prestige segment adjusted operating income | 239.0 | 26 |
| Prestige segment adjusted EBITDA margin | 25.0% | 26 |
| Prestige segment adjusted EBITDA | 267.6 | 26 |
| Prestige percent of total sales | 68% | 27 |
| Other expense | 31.3 | 26 |
| Operating income margin | 11.7% | 26 |
| Operating income | 185.0 | 26 |
| Net revenues | 1577.2 | 26 |
| Net cash used in investing activities | (53.8) | 26 |
| Net cash used in financing activities | (7.6) | 26 |
| Net cash provided by operating activities | 65.2 | 26 |
| Net amount factored | 223.8 | 26 |
| Interest expense, net | 46.6 | 26 |
| Income before income taxes | 107.1 | 26 |
| Gross margin | 35.5% | 26 |
| Gross margin | 64.5% | 27 |
| Free cash flow | 11.2 | 27 |
| Fixed Cost Reduction Plan cash costs life-to-date | 10.0 | 26 |
| Financial net debt | 3,804.7 | 27 |
| Financial leverage ratio | 3.7x | 27 |
| Effective income tax rate | 30.9% | 26 |
| E-commerce penetration percent of sales | approximately 20% | 27 |
| Consumer Beauty segment net revenues | 507.7 | 26 |
| Consumer Beauty segment net revenue | 507.7 | 27 |
| Consumer Beauty segment adjusted operating income margin | 0.3% | 26 |
| Consumer Beauty segment adjusted operating income | 1.5 | 26 |
| Consumer Beauty segment adjusted EBITDA margin | 5.6% | 26 |
| Consumer Beauty segment adjusted EBITDA | 28.5 | 26 |
| Consumer Beauty percent of total sales | 32% | 27 |
| China Prestige business sell-out growth | 15% | 27 |
| Cash flow from operating activities | 65.2 | 27 |
| Cash and cash equivalents | 264.6 | 27 |
| Adjusted operating income margin | 15.2% | 26 |
| Adjusted EBITDA margin | 18.8% | 26 |
| Coty, published 2025-08-21, period FY2025 | ||
| Adjusted operating income margin | 14.5% | 25 |
| Adjusted EBITDA margin | 18.4% | 25 |
| Coty, published 2025-08-20, period FY2025 | ||
| Wella stake value | 1,002.0 million | 24 |
| Reported operating margin | 4.1% | 24 |
| Reported gross margin | 64.8% | 24 |
| Prestige net revenue | 3,820.2 million | 24 |
| Financial net debt | 3,751.3 million | 24 |
| Financial leverage ratio | 3.5x | 24 |
| Economic net debt | 2,749.3 million | 24 |
| E-commerce revenue | 1 billion | 24 |
| Consumer Beauty net revenue | 2,072.7 million | 24 |
| Adjusted operating margin | 14.5% | 24 |
| Adjusted gross margin | 64.9% | 24 |
| Adjusted EBITDA margin (TTM) | 18.4% | 24 |
| Adjusted EBITDA margin | 18.4% | 24 |
| Coty, published 2025-05-07, period 2025-Q3 | ||
| Undrawn letters of credit | 4.1 | 23 |
| Tariff cost estimate | 90.0 to 130.0 | 23 |
| Sally Hansen trademark carrying value | 159.2 | 23 |
| Prestige segment operating income | 78.7 | 23 |
| Prestige segment operating income | 108.7 | 23 |
| Prestige segment net revenues | 829.4 | 23 |
| Prestige segment net revenues | 867.2 | 23 |
| Prestige segment net revenues | 3,059.6 | 23 |
| Prestige segment net revenues | 3,054.5 | 23 |
| Philosophy trademark carrying value | 80.5 | 23 |
| Philosophy impairment | 42.9 | 23 |
| Other brands trademark carrying value | 154.4 | 23 |
| Net cash used in investing activities (prior year) | (161.5) | 23 |
| Net cash used in investing activities | (80.1) | 23 |
| Net cash used in financing activities (prior year) | (264.1) | 23 |
| Net cash used in financing activities | (384.1) | 23 |
| Net cash provided by operating activities (prior year) | 438.1 | 23 |
| Net cash provided by operating activities | 409.4 | 23 |
| Net amount factored (prior year) | 195.3 | 23 |
| Net amount factored | 216.6 | 23 |
| Max Factor trademark carrying value | 64.4 | 23 |
| Max Factor impairment | 84.0 | 23 |
| Forward repurchase contracts cash settlement liability | 53.0 | 23 |
| Fixed Cost Reduction Plan cash costs | 80.0 | 23 |
| CoverGirl trademark carrying value | 266.4 | 23 |
| CoverGirl impairment | 61.0 | 23 |
| Consumer Beauty segment operating loss | (189.5) | 23 |
| Consumer Beauty segment operating loss | (13.3) | 23 |
| Consumer Beauty segment net revenues | 469.7 | 23 |
| Consumer Beauty segment net revenues | 518.4 | 23 |
| Consumer Beauty segment net revenues | 1,580.9 | 23 |
| Consumer Beauty segment net revenues | 1,700.1 | 23 |
| Bourjois trademark carrying value | 11.6 | 23 |
| Bourjois impairment | 24.9 | 23 |
| Bank guarantees | 16.9 | 23 |
| Coty, published 2025-05-06, period 2025-Q3 | ||
| Net debt | $3,615.3 | 22 |
| Economic net debt | $2,615.3 | 22 |
| Wella stake value | 1,000.0 million | 22 |
| Total debt to net loss ratio | 10.2x | 22 |
| Financial net debt | 3,615.3 million | 22 |
| Financial leverage (net debt to adjusted EBITDA) | 3.2x | 22 |
| Economic net debt | 2,615.3 million | 22 |
| Adjusted operating margin | 11.4% | 22 |
| Adjusted operating margin | 16.9% | 22 |
| Adjusted EBITDA margin | 15.7% | 22 |
| Adjusted EBITDA margin | 20.6% | 22 |
| Coty, published 2025-02-10, period 2025-Q2 | ||
| Net cash used in investing activities | (108.2) | 20 |
| Net cash used in financing activities | (461.3) | 20 |
| Net cash provided by operating activities | 531.9 | 20 |
| Gross margin | 66.7% | 20 |
| Adjusted operating income margin | 20.0% | 20 |
| Adjusted EBITDA margin | 23.4% | 20 |
| Coty, published 2025-02-10, period 2025-H1 | ||
| Total debt | 3,459.0 | 21 |
| Net debt | 3,209.4 | 21 |
| Economic net debt | 2,156.4 | 21 |
| Cash and equivalents | 249.6 | 21 |
| Wella Stake Value | $1,053.0 million | 21 |
| Prestige LFL Revenue Growth | 1% | 21 |
| Prestige Fragrance Sell-out Growth | high single digit percentage | 21 |
| Operating Margin Expansion | 240 basis points | 21 |
| Mass Fragrance LFL Growth | mid-single-digit percentage | 21 |
| Gross Margin Improvement | 170 basis points | 21 |
| Financial Net Debt | $3,209.4 million | 21 |
| Financial Leverage Ratio | 2.9x | 21 |
| Economic Net Debt | $2,156.4 million | 21 |
| E-commerce Penetration | approximately 20% | 21 |
| Consumer Beauty LFL Revenue Decline | -4% | 21 |
| Cash from Operating Activities | $531.9 million | 21 |
| Coty, published 2024-11-06, period 2025-Q1 | ||
| Wella Stake Value | 1,085.0 | 19 |
| Travel Retail % of Sales | 9% | 19 |
| Total Debt to Net Income Ratio | 21.1x | 19 |
| Total debt | 4,002.2 | 19 |
| Prestige Segment Revenue | 1,114.1 | 18 |
| Prestige % of Sales | 67% | 19 |
| Operating Margin Reported | 14.2% | 19 |
| Operating Margin Adjusted | 18.2% | 19 |
| Operating Income | 237.8 | 18 |
| Net Revenue | 1,671.5 | 18 |
| Net income attributable to Coty | 82.9 | 18 |
| Net cash from operating activities | 67.4 | 18 |
| Growth engine markets % of sales | approximately 21% | 19 |
| Gross margin reported | 65.5% | 19 |
| Gross margin adjusted | 65.5% | 19 |
| Financial net debt | 3,718.6 | 19 |
| Financial leverage ratio | 3.4x | 19 |
| Economic net debt | 2,633.6 | 19 |
| E-commerce penetration | nearly 20% | 19 |
| Consumer beauty segment revenue | 557.4 | 18 |
| Consumer beauty % of sales | 33% | 19 |
| Adjusted operating margin | 18.2% | 18 |
| adjusted ebitda margin | 21.5% | 18 |
| adjusted ebitda margin | 21.5% | 19 |
| Total debt | $ 4,002.2 | 19 |
| Reported operating income margin | 2.5% | 19 |
| Financial net debt | $ 3,718.6 | 19 |
| Economic net debt | $ 2,633.6 | 19 |
| Cash and cash equivalents | $ 283.6 | 19 |
| Adjusted operating income margin | 4.3% | 19 |
| Adjusted effective tax rate | 28.9% | 19 |
| Adjusted EBITDA margin | 9.4% | 19 |
| Coty, published 2024-08-20, period FY2024 | ||
| Wella Stake Value | 1,085.0 | 16 |
| Travel Retail % of Sales | 9% | 16 |
| Total debt | 3,913.7 | 16 |
| Top 7 licenses average remaining duration | 14 years | 15 |
| Top 7 fragrance licenses % | approximately 82% | 15 |
| Top 7 fragrance brands revenue % | approximately 91% | 15 |
| Top retailer revenue % | approximately 5% | 15 |
| Third-party manufacturing % | approximately 21% | 15 |
| products owned or perpetual license pct | 50% | 15 |
| products exclusive license 6 to 30 years pct | 34% | 15 |
| prestige fragrance revenue pct | approximately 56% | 15 |
| operating cash flow | 614.6 | 16 |
| net debt to adjusted EBITDA | 3.3x | 16 |
| manufacturing in-house pct | approximately 79% | 15 |
| license agreements average duration | over 25 years | 15 |
| impairment charges | 31.4 | 15 |
| Growth engine markets % of sales | approximately 22% | 16 |
| gross margin pct | 64.4 | 16 |
| free cash flow | 369.4 | 16 |
| Financial net debt | 3,612.9 | 16 |
| Economic net debt | 2,527.9 | 16 |
| E-commerce penetration | nearly 20% | 16 |
| countries operating | over 36 countries | 15 |
| countries distributed | approximately 121 countries and territories | 15 |
| brand licenses count | 24 | 15 |
| adjusted gross margin pct | 64.2 | 16 |
| Coty, published 2024-05-06, period 2024-Q3 | ||
| e-commerce penetration | approximately 20% | 13 |
| e-commerce channel net revenue growth | nearly 20% | 13 |
| Wella stake value | 1,080.0 | 13 |
| Total debt | 3,972.3 | 13 |
| Total Debt | 3,972.3 | 13 |
| TTM Net Income from Continuing Operations | 240.5 | 13 |
| TTM Adjusted EBITDA | 1,092.0 | 13 |
| Prestige segment revenue | 867.2 | 13 |
| Free cash flow | 252.7 | 13 |
| Financial net debt | 3,712.1 | 13 |
| financial leverage ratio (net debt to adjusted EBITDA) | 3.4x | 13 |
| Financial Net Debt | 3,712.1 | 13 |
| Expected FY24 cost savings | 110-120 million | 13 |
| Economic net debt | 2,632.1 | 13 |
| Economic Net Debt | 2,632.1 | 13 |
| Cost savings achieved year-to-date | over 90 million | 13 |
| Consumer Beauty segment revenue | 518.4 | 13 |
| Coty, published 2024-02-08, period 2024-Q2 | ||
| Order fill rates | close to pre-COVID-19 service levels | 12 |
| Net cash used in investing activities | (119.4) | 12 |
| Net cash used in financing activities | (285.9) | 12 |
| Net cash from operating activities | 608.1 | 12 |
| Coty, published 2024-02-07, period 2024-Q2 | ||
| Wella stake value | 1.08 billion | 11 |
| Savings year-to-date | approximately 65 million | 11 |
| Savings in Q2 | approximately 30 million | 11 |
| Financial leverage ratio | approximately 3.1x | 11 |
| Financial Net Debt/Adjusted EBITDA | 3.08 | 11 |
| Financial Net Debt | 3.3 billion | 11 |
| Expected FY24 savings | 110-120 million | 11 |
| Economic Net Debt | 2.2 billion | 11 |
| E-commerce revenue growth | over 20% | 11 |
| E-commerce penetration | low 20s percentage | 11 |
| Coty, published 2023-11-08, period 2024-Q1 | ||
| Order fill rates | near pre-COVID-19 service levels | 10 |
| Coty, published 2023-11-07, period 2024-Q1 | ||
| Wella stake value | 1,064.0 | 9 |
| Prestige net revenues | 1,064.7 | 9 |
| Prestige LFL growth | 22% | 9 |
| Operating cash flow | 186.2 | 9 |
| Gross margin | 63.5% | 9 |
| Financial Net Debt to Adjusted EBITDA | 3.84x | 9 |
| EMEA net revenues | 732.2 | 9 |
| Consumer Beauty net revenues | 576.7 | 9 |
| Consumer Beauty LFL growth | 10% | 9 |
| Asia Pacific net revenues | 201.2 | 9 |
| Americas net revenues | 708.0 | 9 |
| Adjusted operating margin | 18.4% | 9 |
| Adjusted EBITDA margin | 22.0% | 9 |
Coty Development
A condensed summary of Coty per reporting period as running text: what changed operationally, which drivers management names, how earnings and cash flow developed. NadirAlpha methodology
FY2026: Coty
Coty reported full-year net revenues of USD 5,806.6 million, a decrease of 2% from the prior year, reflecting a 5% unit volume decline partially offset by 4% favorable foreign currency translation 33. The year resulted in an operating loss of USD 81.5 million and a net loss of USD 604.8 million, driven primarily by asset impairment charges of $362.8 million recorded in the third quarter, comprising a $237.1 million goodwill impairment in the Consumer Beauty segment and $125.7 million in trademark impairments for CoverGirl, Sally Hansen, Max Factor, and Bourjois 33. Adjusted EBITDA margin decreased to 14.6% from 18.4% in the prior year, reflecting revenue declines and cost pressures including manufacturing, freight, and tariff-related costs of $29.3 million after mitigating actions 33. Full-year free cash flow improved to USD 348.2 million from $277.6 million in the prior year, while total debt decreased to $3,088.2 million from $4,008.4 million, supported by $750.0 million in proceeds from the Wella stake sale and active debt redemptions 32 33. Key strategic actions in the year included a leadership transition with Markus Strobel becoming Executive Chairman and Interim CEO in January 2026, the launch of the Coty.Curated strategic framework, and an agreement to sell the Gucci Beauty license back to Kering for $400 million plus inventory proceeds 32 33.
FY2025: Coty
Coty reported full-year net revenues of 5,892.9 million in fiscal 2025, a decline of 4% on a reported basis and 2% on a like-for-like basis, with Prestige net revenues slightly positive on a like-for-like basis and Consumer Beauty net revenues declining 5% like-for-like 24. Coty recorded a full-year net loss of 367.9 million, driven by $212.8 million in asset impairment charges on Max Factor, CoverGirl, Bourjois, and Philosophy trademarks recorded in the third quarter, as well as a $71.0 million loss from termination of the KKW Collaboration Agreement 25. Full-year adjusted EBITDA was $1,081.7 million, down 1% year-over-year, with the adjusted EBITDA margin expanding 60 basis points to 18.4%, supported by gross margin improvement and $140 million in productivity savings under the All-In to Win strategy 24. Free cash flow was 277.6 million for the year, compared to $369.4 million in the prior year, reflecting lower cash profit 24. Coty announced a Fixed Cost Reduction Plan in April 2025 targeting approximately $80.0 million in cash costs and shifted strategic focus from China toward broader emerging markets and the U.S., with e-commerce revenue reaching $1 billion in fiscal 2025 for the first time 24 25.
FY2024: Coty
Coty reported full year net revenues of 6,118 million for fiscal 2024, growing 10% on a reported basis and 11% on a like-for-like basis, outpacing global beauty market growth of approximately 9% 16. Prestige segment net revenues grew 13% reported and 14% like-for-like to $3,857.3 million while Consumer Beauty segment net revenues grew 6% on both a reported and like-for-like basis to $2,260.7 million, with e-commerce channel net revenues growing over approximately 20% across both segments 15 16. Adjusted EBITDA grew 12% to $1,091.1 million, exceeding the full year guidance range of $1,080 to $1,090 million, with an adjusted EBITDA margin of 17.8%, and adjusted operating income reached 863.4 million 16. Financial net debt declined to 3,544 million at fiscal year end as Coty completed multiple debt retirement and refinancing actions including equity offerings and senior secured notes issuances throughout the year 16. The company initiated fiscal 2025 guidance targeting 6-8% like-for-like revenue growth and adjusted EBITDA of $1,186 to $1,208 million, implying 9-11% adjusted EBITDA growth 16.
FY2023: Coty
Coty delivered full-year net revenues of 5,554.1 million in fiscal 2023, up 5% as reported and 12% on a core like-for-like basis, exceeding the company's prior guidance of 9-10% core LFL growth 8. Adjusted operating income of 738.8 million grew 20%, and adjusted EBITDA of $972.8 million surpassed the most recently raised guidance range of $965-970 million despite over $70 million of negative foreign exchange impact 8. Adjusted EPS reached 0.53, reflecting a non-operating benefit of $0.15 from mark-to-market on an equity swap and $0.10 of underlying per-share expansion 8. Financial net debt ended the year at 3,989.2 million, with the financial leverage ratio improving to 4.1x from 4.7x at the close of fiscal 2022 8. Free cash flow totaled 402.9 million, and Coty completed its commercial exit from Russia while terminating the Lacoste fragrance license and recognizing a related gain of $104.4 million during the year 7 8.
Glossary
- Revenue: Revenue from contracts with customers, net of sales deductions, as the company itself reports it; not total output, gross revenue, GMV or order intake.
- Op. income: The operating line of the income statement; EBIT only as a marked fallback, never pre-tax or ordinary income.
- Op. income (adj.): Adjusted operating income, verbatim and company-defined (non-GAAP), never derived.
- EBITDA (adj.): Adjusted EBITDA, verbatim and company-defined (non-GAAP), never derived.
- Net income: Net income attributable to the shareholders of the parent, after discontinued operations; not the result including minority interests, not comprehensive income.
- EPS: Diluted earnings per share attributable to the shareholders of the parent; a printed figure always beats a calculated one, calculated values are marked.
- EPS adj.: Adjusted earnings per share, verbatim and company-defined (non-GAAP).
- FCF: Free cash flow = operating cash flow minus capital expenditure on property, plant and equipment; the company's own free cash flow figure is shown separately.
- OCF: Cash flow from operating activities as reported; IFRS companies may show interest paid in financing cash flow, so the figure is not always comparable.
- Cash: Cash and cash equivalents, without securities unless the company reports them as part of the position.
- Net Debt: Net debt = financial debt excluding lease liabilities minus cash at the same reporting date; the company's own net position may differ.
- *: derived, the formula is in the hover
- ≈: calculated, approximation
- ~: uncertain; the value stays visible, verdicts do not use it
- °: repaired by a targeted query against the document, or curated with documentary evidence
- EBIT: EBIT as a fallback: the income statement carries no operating line
- basic: basic earnings per share as a fallback when diluted is missing
Sources: quarterly reports, annual reports and investor relations documents
56 sources on Coty since 2023; the superscript numbers in the chapters refer to these rows, older documents are in the expandable part. NadirAlpha methodology
Older sources (+23)
| # | Document type | Published |
|---|---|---|
| #201 | 10-Q quarterly report | 2016-05-03 |
| #202 | 10-K annual report | 2016-08-18 |
| #206 | 10-K annual report | 2016-08-18 |
| #203 | 10-Q quarterly report | 2016-11-09 |
| #204 | 10-Q quarterly report | 2017-02-09 |
| #205 | 10-Q quarterly report | 2017-05-10 |
| #210 | 10-K annual report | 2017-08-23 |
| #207 | 10-Q quarterly report | 2017-11-09 |
| #208 | 10-Q quarterly report | 2018-02-08 |
| #209 | 10-Q quarterly report | 2018-05-09 |
| #214 | 10-K annual report | 2018-08-21 |
| #211 | 10-Q quarterly report | 2018-11-07 |
| #212 | 10-Q quarterly report | 2019-02-08 |
| #213 | 10-Q quarterly report | 2019-05-08 |
| #218 | 10-K annual report | 2019-08-28 |
| #215 | 10-Q quarterly report | 2019-11-06 |
| #216 | 10-Q quarterly report | 2020-02-05 |
| #217 | 10-Q quarterly report | 2020-05-11 |
| #222 | 10-K annual report | 2020-08-27 |
| #219 | 10-Q quarterly report | 2020-11-06 |
| #220 | 10-Q quarterly report | 2021-02-09 |
| #221 | 10-Q quarterly report | 2021-05-10 |
| #223 | 10-Q quarterly report | 2021-11-08 |
Coty Stock FAQ
Which additional key figures does Coty report?
As reported for Q4 FY2026 (Apr to Jun 2026): Financial leverage ratio, Total debt, Financial net debt, Total debt to net loss ratio, Prestige net revenues, Consumer Beauty net revenues. The chapter Reported KPIs lists every value with its source. Revenue is broken down by Prestige, Consumer Beauty, EMEA, Americas.
Where can I find the official investor relations documents of Coty?
NadirAlpha links all 56 original filings used (SEC filings) in the sources chapter: earnings release, quarterly report, annual report, each with type, publication date and a direct link; every figure in the report carries a source number.